Bacillus subtilis strain NRRL B-67989
Information
Type
Compositional guidelines
Regulated products
Medical Devices
Topics
Complementary Medicines, Legislation, Listed Medicines, Prescription Medicines, Updates To Listed Medicine Ingredients
Published
June 14, 2024
Last updated
June 14, 2024
Description
Compositional Guideline for Bacillus subtilis strain NRRL B-67989 permitted for use in listed medicines.
Tags
Organization
Country / Region
Australia
License
Other (Non-Commercial)